Comparison of Outcomes between 7-French and 10-French Plastic Stents for Patients with Biliary Tract Cancer = 담도암 환자에서 7-프렌치와 10-프렌치 플라스틱 스텐트의 결과 비교

국문 초록 (Abstract)

배경/목적: 담도암에서 플라스틱 스텐트 너비에 따른 스텐트 생존 차이에 대한 데이터는 부족하다. 이번 연구의 목적은 담도암에서 7-프렌치와 10-프렌치 플라스틱 스텐트의 생존 차이를 보고 어떤 인자가 개방성에 영향을 미치는지 확인하고자 한다.
방법: 2010년 1월부터 2014년 10월까지 연세대학교 원주세브란스기독병원에서 담도암으로 담도가 막힌 환자들을 등록 하였다.
결과: 총 215명(7-프렌치:10-프렌치 = 89명:126명)의 환자를 후향적으로 등록하였다. 암의 위치는 총담관(111명), 간문부 담관(45명), 바터팽대부(59명)였다. 스텐트 이동이나 폐쇄는 두 군 간에 통계적 차이가 없었다. 중앙 스텐트 생존은 7-프렌치의 경우 3.3개월이었고 10-프렌치의 경우 5.9개월이었다(p = 0.543). 플라스틱 스텐트 너비는 스텐트 생존에 영향을 미치지 않았다(Hazard Ratio: 1.11, 95% CI 0.71-1.73, p = 0.649).
결론: 담도암 치료에 있어 7-프렌치와 10-프렌치 플라스틱 스텐트는 스텐트 이동이나 폐쇄 차이가 없었고 스텐트 생존에 있어 7-프렌치 플라스틱 스텐트가 10-프렌치에 비해 열등하지 않았다.

참고문헌 (Reference)

1 Schmassmann A, "Wallstents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival" 91 : 654-659, 1996

2 Kawashima H, "Should plastic stents be avoided in all unresectable malignant perihilar biliary strictures?" (25 Suppl 2) : 86-89, 2013

3 Davids PH, "Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction" 340 : 1488-1492, 1992

4 Smith AC, "Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction" 344 : 1655-1660, 1994

5 Andersen JR, "Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice" 30 : 1132-1135, 1989

6 Huibregtse K, "Palliative treatment of obstructive jaundice by transpapillary introduction of large bore bile duct endoprosthesis" 23 : 371-375, 1982

7 Soehendra N, "Palliative bile duct drainage - a new endoscopic method of introducing a transpapillary drain" 12 : 8-11, 1980

8 Abraham NS, "Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life" 56 : 835-841, 2002

9 Frakes JT, "Optimal timing for stent replacement in malignant biliary tract obstruction" 39 : 164-167, 1993

10 Siegel JH, "Optimal palliation of malignant bile duct obstruction: experience with endoscopic 12 French prostheses" 20 : 137-141, 1988

11 Sasahira N, "Multicenter study of endoscopic preoperative biliary drainage for malignant distal biliary obstruction" 22 : 3793-3802, 2016

12 Wagh MS, "Multicenter randomized trial of 10-French versus 11.5-French plastic stents for malignant biliary obstruction" 2013 : 891915-, 2013

13 Siegel JH, "Improved biliary decompression with large caliber endoscopic prostheses" 30 : 21-23, 1984

14 Matsuda Y, "Factors affecting the patency of stents in malignant biliary obstructive disease: univariate and multivariate analysis" 86 : 843-849, 1991

15 Rey JF, "Experimental study of biliary endoprosthesis efficiency" 17 : 145-148, 1985

16 Pedersen FM, "Endoscopic management of malignant biliary obstruction. Is stent size of 10 French gauge better than 7 French gauge?" 28 : 185-189, 1993

17 Raikar GV, "Cost-effective analysis of surgical palliation versus endoscopic stenting in the management of unresectable pancreatic cancer" 3 : 470-475, 1996

18 Kadakia SC, "Comparison of 10 French gauge stent with 11.5French gauge stent in patients with biliary tract diseases" 38 : 454-459, 1992

19 Lee KJ, "Clinical advantages of a metal stent with an S-shaped anti-reflux valve in malignant biliary obstruction" 25 : 308-312, 2013

20 Taylor MC, "Biliary stenting versus bypass surgery for the palliation of malignant distal bile duct obstruction: a metaanalysis" 6 : 302-308, 2000

21 Somogyi L, "Biliary and pancreatic stents" 63 : 910-919, 2006